Alm El-Din MA - Search Results

1

Celecoxib as an adjuvant to chemotherapy for patients with metastatic colorectal cancer: A randomized controlled clinical study.

Mostafa TM, Alm El-Din MA, Rashdan AR. Mostafa TM, et al. Among authors: alm el din ma. Saudi Med J. 2022 Jan;43(1):37-44. doi: 10.15537/smj.2022.43.1.20210574. Saudi Med J. 2022. PMID: 35022282 Free PMC article. Clinical Trial.

2

Cytokeratin-19 fragments, nucleosomes and neuron-specific enolase as early measures of chemotherapy response in non-small cell lung cancer.

Alm El-Din MA, Farouk G, Nagy H, Abd Elzaher A, Abo El-Magd GH. Alm El-Din MA, et al. Int J Biol Markers. 2012 Jul 19;27(2):e139-46. doi: 10.5301/JBM.2012.9141. Int J Biol Markers. 2012. PMID: 22467097 Free article.

3

The role of chemokine CC ligand 20 in patients with liver cirrhosis and hepatocellular carcinoma.

Soliman HH, Nagy H, Kotb N, Alm El-Din MA. Soliman HH, et al. Among authors: alm el din ma. Int J Biol Markers. 2012 Jul 19;27(2):e125-31. doi: 10.5301/JBM.2012.9097. Int J Biol Markers. 2012. PMID: 22388957 Free article.

4

Breast conservation therapy for patients with locally advanced breast cancer.

Alm El-Din MA, Taghian AG. Alm El-Din MA, et al. Semin Radiat Oncol. 2009 Oct;19(4):229-35. doi: 10.1016/j.semradonc.2009.05.005. Semin Radiat Oncol. 2009. PMID: 19732687 Review.

5

Evaluation of radiation-induced cardiac toxicity in breast cancer patients treated with Trastuzumab-based chemotherapy.

Abouegylah M, Braunstein LZ, Alm El-Din MA, Niemierko A, Salama L, Elebrashi M, Edgington SK, Remillard K, Napolitano B, Naoum GE, Sayegh HE, Gillespie T, Farouk M, Ismail AA, Taghian AG. Abouegylah M, et al. Among authors: alm el din ma. Breast Cancer Res Treat. 2019 Feb;174(1):179-185. doi: 10.1007/s10549-018-5053-y. Epub 2018 Nov 26. Breast Cancer Res Treat. 2019. PMID: 30478787 Free PMC article.

6

Significance of autotaxin activity and overexpression in comparison to soluble intercellular adhesion molecule in thyroid cancer.

Hassan AM, Alm El-Din MA, Nagy H, Ghoneem N, El-Heniedy MA, Koteb N, El-Gohary S. Hassan AM, et al. Among authors: alm el din ma. Int J Biol Markers. 2013 Apr 23;28(1):84-91. doi: 10.5301/JBM.2013.10780. Int J Biol Markers. 2013. PMID: 23558934 Free article.

7

Lumpectomy and partial breast irradiation for early-stage breast cancer following mantle irradiation for Hodgkin's lymphoma.

Alm El-Din MA, Feng JK, Taghian AG. Alm El-Din MA, et al. Nat Clin Pract Oncol. 2008 Jul;5(7):426-9. doi: 10.1038/ncponc1135. Epub 2008 May 20. Nat Clin Pract Oncol. 2008. PMID: 18493230

8

Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter.

Alm El-Din MA, Hughes KS, Finkelstein DM, Betts KA, Yock TI, Tarbell NJ, Aisenberg AC, Taghian AG. Alm El-Din MA, et al. Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):69-74. doi: 10.1016/j.ijrobp.2008.03.066. Epub 2008 Jun 4. Int J Radiat Oncol Biol Phys. 2009. PMID: 18538497

9

Breast cancer after treatment of Hodgkin's lymphoma: general review.

Alm El-Din MA, El-Badawy SA, Taghian AG. Alm El-Din MA, et al. Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1291-7. doi: 10.1016/j.ijrobp.2008.07.060. Int J Radiat Oncol Biol Phys. 2008. PMID: 19028269 Review.

10

Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy.

Macdonald SM, Abi-Raad RF, Alm El-Din MA, Niemierko A, Kobayashi W, McGrath JJ, Goldberg SI, Powell S, Smith B, Taghian AG. Macdonald SM, et al. Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1297-303. doi: 10.1016/j.ijrobp.2009.01.007. Epub 2009 Mar 26. Int J Radiat Oncol Biol Phys. 2009. PMID: 19327896

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page